StrokeNCT07006818
Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function
A study testing Direct current stimulation in people with Stroke, run by University of Illinois Chicago at 1 site in United States.
Trial summary
Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. Read more about this study
- Who is it for?
- Ages 25 to 90 years
- Conditions the study is for
- Stroke
- What is being tested?
- Direct current stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Sep 2025to 30 Apr 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age: 25 - 90 years of age
- Monohemispheric stroke
- Chronic phase (> 6 months post stroke)
- Ability to walk for at least 6 minutes at a self-selected comfortable speed
Who cannot join
- Lesions affecting the brainstem or cerebellum
- Other neurological disorders
- Current botox treatments for the lower limb
- Significant cognitive or communication impairment
- TMS exclusion criteria
- Previous adverse reaction to TMS
Show all 23Show fewer
- Skull abnormalities or fractures
- Concussion within the prior 6 months
- Unexplained, recurring headaches
- Implanted cardiac pacemaker
- Metal implants in the head or face
- History of seizures or epilepsy
- Use of medications that could increase risk of seizure
- Current pregnancy
- PNS \& DCS exclusion criteria
- Skin hypersensitivity at any sites of stimulation, including the scalp, thoracolumbar spine, and peripheral limbs
- History of contact dermatitis at any of the sites of stimulation
- History of allodynia and/or hyperalgesia
- Active skin infection
- Skin lesions
- Deep vein thrombosis
- Any other skin or scalp condition that could be aggravated by stimulation
- Implanted electronic, metallic, or highly conductive devices near site of stimulation that cannot be removed without permission from a health professional
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Illinois at Chicago
Chicago, Illinois, 60612
About this study
Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. One novel target for stroke gait rehabilitation is interlimb coordination-the phase-dependent cyclical relation of the legs. Interlimb coordination is altered during walking after stroke, compromising walking stability, phase transitions, and responses to perturbation and contributing to motor compensation. It is unclear what neural pathways contribute to impaired interlimb coordination after stroke and what impact this has on walking-related outcomes.
This proposal consists of two aims to address these issues, with the long-term goal of developing therapeutic interventions to improve interlimb coordination and walking after stroke.
Read more
Aim 1 will identify which neural sources contribute to impaired interlimb coordination after stroke. During bilateral, cyclical recumbent stepping (analogue of walking), interlimb coordination will be assessed as relative leg phasing. During the task, transcranial magnetic stimulation and peripheral nerve stimulation will be applied to assess supraspinal, interhemispheric, spinal interneuronal, and sensory pathways. The relation of interlimb coordination with these outcomes will be assessed to determine potential contributors.
Aim 2 will test the association between interlimb coordination and walking after stroke. Interlimb coordination will be quantified during split-belt treadmill walking, and associations with walking speed, endurance, mobility, independence, daily activity, quality of life, and community engagement will be tested.
An additional exploratory aim will determine the effect of targeted neuromodulation on lower limb interlimb coordination. Electrical stimulation will be applied to three locations in a cross-over study: the primary motor cortex (supraspinal/interhemispheric), thoracolumbar spine (spinal interneuronal), and peripheral nerves (sensory).
Read the detailed description
Walking problems are common, disruptive, and persistent after stroke. Of 9.4 million people in the U.S. with chronic stroke, most have long-term walking problems such as decreased walking speed and endurance, and ~36% (~3.4 million) cannot walk independently. These walking issues have secondary impacts, including limited community integration, impaired quality of life, decreased physical activity, increased risk of other diseases and disabilities, and ~$56 billion in annual costs. Hence, a major goal of stroke rehabilitation research is to improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb without regard for the less affected limb or focused on improving walking function (e.g., maximizing walking speed) without regard for how improvements are achieved. Unfortunately, walking limitations persist even after intensive rehabilitation, perhaps because these current approaches do not adequately address the complex neural control required for walking.
Interlimb coordination is essential for walking, but impaired after stroke. One construct that reflects the complex control of walking is interlimb coordination, the phase-dependent cyclical relation of the legs [and arms]. Bipedal locomotion cannot occur without interlimb coordination, and precise control is essential for stability, phase transitions, and responses to perturbations. After stroke, interlimb coordination becomes impaired. The investigators and others have shown that during bilateral, cyclical leg movements (e.g., walking and pedaling), the phase relation between the legs is abnormal and highly variable after stroke. Lower limb muscle activity has abnormal timing and amplitude that is exacerbated during bilateral movements, and ankle motor control is worse during bilateral than unilateral movement.
Impaired interlimb coordination may contribute to worsened walking-related outcomes. Impaired interlimb coordination after stroke increases metabolic cost of walking, compromises responses to perturbation, and contributes to detrimental behaviors like motor compensation. However, it is unclear how impaired interlimb coordination impacts walking. Some studies have shown that impaired interlimb coordination is related to reduced walking speed (or pedaling velocity), but others have found no association. Although the relation of walking with interlimb coordination is unclear, related constructs (spatiotemporal asymmetry and variability) are associated with walking. Spatiotemporal asymmetry is associated with motor impairment and slower walking, and spatiotemporal variability is related to fall risk and reduced community ambulation.
Interlimb coordination is a distinct construct that is understudied. One reason why few studies have investigated interlimb coordination after stroke is that much prior work has used walking symmetry as a measure of interlimb coordination. However, less than 50% of the variance in interlimb coordination is explained by measures of symmetry, symmetry does not reflect the phase-dependent relation between limbs, and asymmetrical movements may be appropriate and well-coordinated. These data suggest that symmetry and interlimb coordination are distinct features of gait. Also, symmetry may offer limited insight into walking; improvements in symmetry and in walking are not associated, and targeting symmetry does not benefit walking more than other approaches. In contrast, measures that fully reflect interlimb coordination patterns during walking (e.g., muscle activation, kinetic, or kinematic patterns) may better inform walking rehabilitation.
Interlimb coordination has multi-level neural control, but which neural pathways contribute to impaired interlimb coordination after stroke is unclear. During walking, interlimb coordination is controlled via supraspinal, spinal interneuronal, and sensory pathways. Supraspinal motor regions have bilateral effects via ipsilateral uncrossed (e.g., corticospinal, reticulospinal) and interhemispheric pathways. Spinal interneuronal pathways control bilateral locomotor rhythms, and interlimb sensory pathways provide essential input to supraspinal regions, spinal circuits, and motoneurons. Each pathway contributes to interlimb coordination, and there is a complex interplay between pathways. Supraspinal descending pathways modulate spinal interneuronal and sensory pathways; sensory pathways are modulated by spinal interneuronal circuits; and spinal interneuronal circuits depend on sensory inputs. Stroke causes imbalanced transcallosal pathways and altered strength of bilateral motor tracts and causes secondary changes in descending supraspinal modulation of spinal interneuronal and sensory pathways, leading to altered function of these pathways For example, crossed limb reflexes, H-reflexes, and cutaneous reflexes all have abnormal timing and amplitude during walking and pedaling after stroke, and sensory loss is common after stroke. These changes may contribute to impaired interlimb coordination and walking disability after stroke. Despite its essential role for walking, there has been minimal work that investigates interlimb coordination and seeks to identify the neural sources of impairment after stroke.
Targeting interlimb coordination may improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb with little focus on interlimb interactions or improving walking function (e.g., maximizing walking speed) without regard for movement quality. These approaches may have achieved limited success because they ignore the essential role of interlimb coordination for walking. Yet, few interventions have targeted interlimb interactions, largely because interlimb coordination has been conflated with symmetry and can be more expensive to measure. Interventions to target interlimb coordination during walking include: 1) promoting an antiphasic interlimb pattern (e.g., using visual or audio cues); 2) stimulating coordinated bilateral responses (e.g., perturbing walking surface stiffness on a variable stiffness treadmill to evoke responses to maintain coordination and stability); and 3) augmenting interlimb phasing errors with a split-belt treadmill to elicit aftereffect improvements in coordination. Repeated interlimb coordination training may yield improvements in walking. Moreover, determining the neural sources of impaired interlimb coordination could reveal additional targets for intervention. For example, neuromodulatory stimulation of supraspinal, spinal interneuronal, and/or sensory pathways may serve as a powerful adjuvant to interlimb coordination training.
The aims of this proposal address several issues that must be resolved before interlimb coordination can be effectively targeted: 1) identifying the relative contributions of supraspinal, spinal interneuronal, and sensory pathways to interlimb coordination impairments after stroke, and 2) determining the association between interlimb coordination and walking.
- Conditions
- Stroke
- Being tested
- Direct current stimulation
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Direct current stimulationDevice
Direct current stimulation will be applied at 2 mA for 20 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Supraspinal direct current stimulation | Experimental | Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the ipsilesional primary motor cortex and the cathode applied to the contralesional supraorbit. Receives: Device: Direct current stimulation |
| Spinal direct current stimulation | Experimental | Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the thoracic vertebra and the cathode applied to the non-paretic shoulder. Receives: Device: Direct current stimulation |
| Sensory direct current stimulation | Experimental | Participants will receive 2 mA direct current stimulation for 20 minutes, with the anode and the cathode applied to the cutaneous superficial peroneal nerve. Receives: Device: Direct current stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Corticomotor excitability
Transcranial magnetic stimulation (TMS) will be used to measure change in contralateral and ipsilateral corticomotor excitability of the paretic tibialis anterior, medial gastrocnemius, rectus femoris, and biceps femoris. TMS will be applied at different intensities, and the response (motor evoked potential) is measured in the paretic TMS. Corticomotor excitability will be measured as the slope of the input output curve (intensity vs. response). Higher values represent greater corticomotor excitability.
Measured: immediately before and after immediately after the intervention
Cutaneous reflexes
A train of 5 short duration (1 ms) electrical pulses at ~300 Hz will be applied to the cutaneous superficial peroneal nerve. These pulses elicit reflex responses in muscles throughout the leg (cutaneous reflexes). Amplitude of muscle activation during stimulation will be compared to periods without stimulation.
Measured: immediately before and after immediately after the intervention
H-reflexes
1ms electrical pulses will be applied to the deep fibular (peroneal) nerve. Two evoked potentials (M-wave and H-reflex) in the muscle that will be recorded with electromyography (EMG). Stimulations will be applied at a variety of intensities ranging from 70% of H-reflex threshold up to 120% of M-Max. M and H input-output curves will be generated. We will extract the maximal H-reflex response at any intensity (H-max), calculate the H-max/M-max ratio, and determine the slope of the ascending portion of the H-reflex curve (determined with a sigmoidal function).
Measured: immediately before and after immediately after the intervention
Secondary outcomes (1)
Interhemispheric inhibition
Transcranial magnetic stimulation (TMS) will be applied to both hemispheres and responses (silent period duration) will be measured in the ipsilateral limb. Higher values represent greater interhemispheric inhibition.
Measured: immediately before and after immediately after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2025
- Study start15 Sep 2025
- Primary completion30 Apr 2027 (estimated)
- Study completion30 Apr 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by University of Illinois ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Illinois Chicago
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Brice Cleland, University of Illinois Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07006818
- Sponsor's protocol ID
- UIC EXITO Pilot 2025
- Status last verified
- Aug 2026
- First submitted
- 27 May 2025
- Last updated
- 21 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All underlying data for this study will be deidentified and then will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function
- ClinicalTrials.gov ID
- NCT07006818
- Acronym / sponsor ID
- UIC EXITO Pilot 2025
- Conditions
- Stroke
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- University of Illinois ChicagoUniversity, hospital or other
- Study start
- 15 Sep 2025 (actual)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 Apr 2028 (estimated)
- First posted
- 5 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. One novel target for stroke gait rehabilitation is interlimb coordination-the phase-dependent cyclical relation of the legs. Interlimb coordination is altered during walking after stroke, compromising walking stability, phase transitions, and responses to perturbation and contributing to motor compensation. It is unclear what neural pathways contribute to impaired interlimb coordination after stroke and what impact this has on walking-related outcomes.
This proposal consists of two aims to address these issues, with the long-term goal of developing therapeutic interventions to improve interlimb coordination and walking after stroke.
Aim 1 will identify which neural sources contribute to impaired interlimb coordination after stroke. During bilateral, cyclical recumbent stepping (analogue of walking), interlimb coordination will be assessed as relative leg phasing. During the task, transcranial magnetic stimulation and peripheral nerve stimulation will be applied to assess supraspinal, interhemispheric, spinal interneuronal, and sensory pathways. The relation of interlimb coordination with these outcomes will be assessed to determine potential contributors.
Aim 2 will test the association between interlimb coordination and walking after stroke. Interlimb coordination will be quantified during split-belt treadmill walking, and associations with walking speed, endurance, mobility, independence, daily activity, quality of life, and community engagement will be tested.
An additional exploratory aim will determine the effect of targeted neuromodulation on lower limb interlimb coordination. Electrical stimulation will be applied to three locations in a cross-over study: the primary motor cortex (supraspinal/interhemispheric), thoracolumbar spine (spinal interneuronal), and peripheral nerves (sensory).
Detailed description
Walking problems are common, disruptive, and persistent after stroke. Of 9.4 million people in the U.S. with chronic stroke, most have long-term walking problems such as decreased walking speed and endurance, and ~36% (~3.4 million) cannot walk independently. These walking issues have secondary impacts, including limited community integration, impaired quality of life, decreased physical activity, increased risk of other diseases and disabilities, and ~$56 billion in annual costs. Hence, a major goal of stroke rehabilitation research is to improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb without regard for the less affected limb or focused on improving walking function (e.g., maximizing walking speed) without regard for how improvements are achieved. Unfortunately, walking limitations persist even after intensive rehabilitation, perhaps because these current approaches do not adequately address the complex neural control required for walking.
Interlimb coordination is essential for walking, but impaired after stroke. One construct that reflects the complex control of walking is interlimb coordination, the phase-dependent cyclical relation of the legs [and arms]. Bipedal locomotion cannot occur without interlimb coordination, and precise control is essential for stability, phase transitions, and responses to perturbations. After stroke, interlimb coordination becomes impaired. The investigators and others have shown that during bilateral, cyclical leg movements (e.g., walking and pedaling), the phase relation between the legs is abnormal and highly variable after stroke. Lower limb muscle activity has abnormal timing and amplitude that is exacerbated during bilateral movements, and ankle motor control is worse during bilateral than unilateral movement.
Impaired interlimb coordination may contribute to worsened walking-related outcomes. Impaired interlimb coordination after stroke increases metabolic cost of walking, compromises responses to perturbation, and contributes to detrimental behaviors like motor compensation. However, it is unclear how impaired interlimb coordination impacts walking. Some studies have shown that impaired interlimb coordination is related to reduced walking speed (or pedaling velocity), but others have found no association. Although the relation of walking with interlimb coordination is unclear, related constructs (spatiotemporal asymmetry and variability) are associated with walking. Spatiotemporal asymmetry is associated with motor impairment and slower walking, and spatiotemporal variability is related to fall risk and reduced community ambulation.
Interlimb coordination is a distinct construct that is understudied. One reason why few studies have investigated interlimb coordination after stroke is that much prior work has used walking symmetry as a measure of interlimb coordination. However, less than 50% of the variance in interlimb coordination is explained by measures of symmetry, symmetry does not reflect the phase-dependent relation between limbs, and asymmetrical movements may be appropriate and well-coordinated. These data suggest that symmetry and interlimb coordination are distinct features of gait. Also, symmetry may offer limited insight into walking; improvements in symmetry and in walking are not associated, and targeting symmetry does not benefit walking more than other approaches. In contrast, measures that fully reflect interlimb coordination patterns during walking (e.g., muscle activation, kinetic, or kinematic patterns) may better inform walking rehabilitation.
Interlimb coordination has multi-level neural control, but which neural pathways contribute to impaired interlimb coordination after stroke is unclear. During walking, interlimb coordination is controlled via supraspinal, spinal interneuronal, and sensory pathways. Supraspinal motor regions have bilateral effects via ipsilateral uncrossed (e.g., corticospinal, reticulospinal) and interhemispheric pathways. Spinal interneuronal pathways control bilateral locomotor rhythms, and interlimb sensory pathways provide essential input to supraspinal regions, spinal circuits, and motoneurons. Each pathway contributes to interlimb coordination, and there is a complex interplay between pathways. Supraspinal descending pathways modulate spinal interneuronal and sensory pathways; sensory pathways are modulated by spinal interneuronal circuits; and spinal interneuronal circuits depend on sensory inputs. Stroke causes imbalanced transcallosal pathways and altered strength of bilateral motor tracts and causes secondary changes in descending supraspinal modulation of spinal interneuronal and sensory pathways, leading to altered function of these pathways For example, crossed limb reflexes, H-reflexes, and cutaneous reflexes all have abnormal timing and amplitude during walking and pedaling after stroke, and sensory loss is common after stroke. These changes may contribute to impaired interlimb coordination and walking disability after stroke. Despite its essential role for walking, there has been minimal work that investigates interlimb coordination and seeks to identify the neural sources of impairment after stroke.
Targeting interlimb coordination may improve walking. Most walking rehabilitation approaches have focused on restoring neurotypical patterns in the more affected limb with little focus on interlimb interactions or improving walking function (e.g., maximizing walking speed) without regard for movement quality. These approaches may have achieved limited success because they ignore the essential role of interlimb coordination for walking. Yet, few interventions have targeted interlimb interactions, largely because interlimb coordination has been conflated with symmetry and can be more expensive to measure. Interventions to target interlimb coordination during walking include: 1) promoting an antiphasic interlimb pattern (e.g., using visual or audio cues); 2) stimulating coordinated bilateral responses (e.g., perturbing walking surface stiffness on a variable stiffness treadmill to evoke responses to maintain coordination and stability); and 3) augmenting interlimb phasing errors with a split-belt treadmill to elicit aftereffect improvements in coordination. Repeated interlimb coordination training may yield improvements in walking. Moreover, determining the neural sources of impaired interlimb coordination could reveal additional targets for intervention. For example, neuromodulatory stimulation of supraspinal, spinal interneuronal, and/or sensory pathways may serve as a powerful adjuvant to interlimb coordination training.
The aims of this proposal address several issues that must be resolved before interlimb coordination can be effectively targeted: 1) identifying the relative contributions of supraspinal, spinal interneuronal, and sensory pathways to interlimb coordination impairments after stroke, and 2) determining the association between interlimb coordination and walking.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Supraspinal direct current stimulation | Experimental | Device: Direct current stimulationParticipants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the ipsilesional primary motor cortex and the cathode applied to the contralesional supraorbit. |
| Spinal direct current stimulation | Experimental | Device: Direct current stimulationParticipants will receive 2 mA direct current stimulation for 20 minutes, with the anode applied to the thoracic vertebra and the cathode applied to the non-paretic shoulder. |
| Sensory direct current stimulation | Experimental | Device: Direct current stimulationParticipants will receive 2 mA direct current stimulation for 20 minutes, with the anode and the cathode applied to the cutaneous superficial peroneal nerve. |
Who may qualify
- Ages
- 25 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age: 25 - 90 years of age
- Monohemispheric stroke
- Chronic phase (> 6 months post stroke)
- Ability to walk for at least 6 minutes at a self-selected comfortable speed
Key exclusion criteria (23 listed)
- Lesions affecting the brainstem or cerebellum
- Other neurological disorders
- Current botox treatments for the lower limb
- Significant cognitive or communication impairment
- TMS exclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Direct current stimulationDirect current stimulation will be applied at 2 mA for 20 minutes. | Device | Sensory direct current stimulation, Spinal direct current stimulation, Supraspinal direct current stimulation |
Primary outcome
Corticomotor excitability
Time frame: immediately before and after immediately after the intervention
Transcranial magnetic stimulation (TMS) will be used to measure change in contralateral and ipsilateral corticomotor excitability of the paretic tibialis anterior, medial gastrocnemius, rectus femoris, and biceps femoris. TMS will be applied at different intensities, and the response (motor evoked potential) is measured in the paretic TMS. Corticomotor excitability will be measured as the slope of the input output curve (intensity vs. response). Higher values represent greater corticomotor excitability.
Cutaneous reflexes
Time frame: immediately before and after immediately after the intervention
A train of 5 short duration (1 ms) electrical pulses at ~300 Hz will be applied to the cutaneous superficial peroneal nerve. These pulses elicit reflex responses in muscles throughout the leg (cutaneous reflexes). Amplitude of muscle activation during stimulation will be compared to periods without stimulation.
H-reflexes
Time frame: immediately before and after immediately after the intervention
1ms electrical pulses will be applied to the deep fibular (peroneal) nerve. Two evoked potentials (M-wave and H-reflex) in the muscle that will be recorded with electromyography (EMG). Stimulations will be applied at a variety of intensities ranging from 70% of H-reflex threshold up to 120% of M-Max. M and H input-output curves will be generated. We will extract the maximal H-reflex response at any intensity (H-max), calculate the H-max/M-max ratio, and determine the slope of the ascending portion of the H-reflex curve (determined with a sigmoidal function).
1 secondary outcome
Interhemispheric inhibition
Time frame: immediately before and after immediately after the intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2026.
- Individual participant dataSharing planned: Yes. All underlying data for this study will be deidentified and then will be shared.
Related trials for Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Direct current stimulation in people with Stroke, run by University of Illinois Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Corticomotor excitability (time frame: immediately before and after immediately after the intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.